Nuveen Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$523K Hold
317,271
﹤0.01% 2971
2024
Q3
$1.11M Sell
317,271
-6,733
-2% -$23.6K ﹤0.01% 2715
2024
Q2
$1.06M Buy
324,004
+24,348
+8% +$79.9K ﹤0.01% 2701
2024
Q1
$2.2M Sell
299,656
-14,915
-5% -$109K ﹤0.01% 2360
2023
Q4
$1.18M Buy
314,571
+27,621
+10% +$103K ﹤0.01% 2666
2023
Q3
$608K Sell
286,950
-1,771
-0.6% -$3.76K ﹤0.01% 2777
2023
Q2
$1.37M Buy
288,721
+68,144
+31% +$324K ﹤0.01% 2505
2023
Q1
$1.26M Sell
220,577
-76,906
-26% -$439K ﹤0.01% 2518
2022
Q4
$3M Buy
297,483
+37,533
+14% +$379K ﹤0.01% 2196
2022
Q3
$5.83M Sell
259,950
-172,300
-40% -$3.86M ﹤0.01% 1813
2022
Q2
$10.7M Sell
432,250
-62,794
-13% -$1.56M ﹤0.01% 1460
2022
Q1
$18.7M Buy
495,044
+36,996
+8% +$1.4M 0.01% 1230
2021
Q4
$26.8M Sell
458,048
-18,183
-4% -$1.06M 0.01% 1050
2021
Q3
$28.2M Buy
476,231
+7,367
+2% +$437K 0.01% 1030
2021
Q2
$40.7M Buy
468,864
+9,839
+2% +$854K 0.01% 861
2021
Q1
$37.8M Sell
459,025
-5,729
-1% -$472K 0.01% 884
2020
Q4
$42.3M Sell
464,754
-34,769
-7% -$3.16M 0.01% 783
2020
Q3
$20M Sell
499,523
-31,457
-6% -$1.26M 0.01% 1066
2020
Q2
$18.2M Buy
530,980
+142,207
+37% +$4.88M 0.01% 1109
2020
Q1
$8.64M Buy
388,773
+46,368
+14% +$1.03M ﹤0.01% 1387
2019
Q4
$6.7M Buy
342,405
+28,253
+9% +$553K ﹤0.01% 1834
2019
Q3
$4.88M Buy
314,152
+14,739
+5% +$229K ﹤0.01% 1966
2019
Q2
$6.08M Buy
299,413
+239,253
+398% +$4.86M ﹤0.01% 1875
2019
Q1
$1.06M Sell
60,160
-17,839
-23% -$313K 0.01% 732
2018
Q4
$1M Sell
77,999
-15,888
-17% -$204K 0.01% 716
2018
Q3
$1.53M Buy
93,887
+10,619
+13% +$173K 0.01% 689
2018
Q2
$944K Buy
83,268
+29,205
+54% +$331K 0.01% 744
2018
Q1
$528K Buy
+54,063
New +$528K ﹤0.01% 881